Two Sigma Investments, LP Eiger Bio Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.93 $6,804 - $22,599	-24,300 Reduced 57.58%	17,900 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $1.26 $13,090 - $29,988	-23,800 Reduced 36.06%	42,200 $29,000
Q1 2023 May 15, 2023	SELL	$0.89 - $2.52 $197,882 - $560,296	-222,340 Reduced 77.11%	66,000 $59,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $242,475 - $1.78 Million	237,721 Added 469.63%	288,340 $340,000
Q3 2022 Nov 14, 2022	SELL	$6.04 - $9.66 $68,523 - $109,592	-11,345 Reduced 18.31%	50,619 $381,000
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $174,011 - $312,453	34,872 Added 128.72%	61,964 $390,000
Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $104,033 - $263,876	27,092 New	27,092 $225,000
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $138,378 - $221,351	-27,027 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.68 - $9.1 $46,793 - $63,745	-7,005 Reduced 20.58%	27,027 $181,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.23 $1.13 Million - $1.33 Million	-144,135 Reduced 80.9%	34,032 $290,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $547,435 - $821,152	-64,862 Reduced 26.69%	178,167 $1.58 Million
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $290,926 - $448,056	-36,457 Reduced 13.04%	243,029 $2.99 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $453,576 - $707,716	56,982 Added 25.61%	279,486 $2.28 Million
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $59,437 - $147,163	11,007 Added 5.2%	222,504 $2.14 Million
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $550,082 - $1.65 Million	112,033 Added 112.64%	211,497 $1.44 Million
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $726,409 - $1.16 Million	74,351 Added 296.07%	99,464 $1.48 Million
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $501,806 - $627,912	-52,326 Reduced 67.57%	25,113 $257,000
Q2 2019 Aug 14, 2019	SELL	$9.54 - $14.96 $27,437 - $43,024	-2,876 Reduced 3.58%	77,439 $821,000
Q1 2019 May 15, 2019	BUY	$10.31 - $14.38 $409,008 - $570,468	39,671 Added 97.61%	80,315 $1.12 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $135,663 - $194,928	15,720 Added 63.07%	40,644 $413,000
Q3 2018 Nov 14, 2018	SELL	$9.6 - $12.9 $226,627 - $304,530	-23,607 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $195,938 - $396,597	23,607 New	23,607 $288,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account